Exicure Ebit Per Revenue vs Total Revenue Analysis

XCUR Stock

USD 27.69 0.95 3.55%

Exicure financial indicator trend analysis is much more than just examining Exicure latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Exicure is a good investment. Please check the relationship between Exicure Ebit Per Revenue and its Total Revenue accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Exicure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

To learn how to invest in Exicure Stock, please use our How to Invest in Exicure guide.

Ebit Per Revenue vs Total Revenue

Ebit Per Revenue vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Exicure Ebit Per Revenue account and Total Revenue. At this time, the significance of the direction appears to have no relationship.

The correlation between Exicure's Ebit Per Revenue and Total Revenue is 0.05. Overlapping area represents the amount of variation of Ebit Per Revenue that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Exicure, assuming nothing else is changed. The correlation between historical values of Exicure's Ebit Per Revenue and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit Per Revenue of Exicure are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Ebit Per Revenue i.e., Exicure's Ebit Per Revenue and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.05

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Ebit Per Revenue

Total Revenue

Total revenue comprises all receipts Exicure generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Exicure's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Exicure current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Exicure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

To learn how to invest in Exicure Stock, please use our How to Invest in Exicure guide.As of 11/27/2024, Enterprise Value is likely to grow to about 45.5 M, while Selling General Administrative is likely to drop slightly above 9.7 M.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	62.1M	30.7M	14.1M	13.4M
Cost Of Revenue	1.8M	1.9M	920K	874K

Total Operating Expenses Cost Of Revenue

Exicure fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Capital Surpluse	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Property Plant Equipment	Short Long Term Debt Total	Current Deferred Revenue	Long Term Debt
Total Assets		0.44	0.8	0.89	-0.06	0.78	0.45	-0.5	-0.2	0.59	0.84	0.38	-0.21	0.47	0.97	-0.41	0.45	0.87	0.7	0.51	0.81	0.98	0.05	0.56	0.3	0.42
Other Current Liab	0.44		0.8	0.02	0.24	0.13	0.52	-0.19	-0.3	0.76	0.49	0.64	-0.17	0.62	0.3	-0.44	0.26	0.16	0.53	0.34	0.84	0.32	0.34	0.47	0.2	0.25
Total Current Liabilities	0.8	0.8		0.5	0.21	0.53	0.45	-0.45	-0.33	0.8	0.73	0.52	-0.13	0.49	0.72	-0.51	0.44	0.58	0.55	0.5	0.93	0.74	0.28	0.39	0.41	0.45
Total Stockholder Equity	0.89	0.02	0.5		-0.32	0.72	0.15	-0.59	0.07	0.24	0.78	0.02	-0.31	0.14	0.95	-0.13	0.23	0.81	0.44	0.28	0.46	0.94	-0.24	0.33	0.19	0.21
Other Liab	-0.06	0.24	0.21	-0.32		0.31	0.65	0.63	-0.94	0.5	-0.43	0.72	0.88	0.51	-0.25	-0.52	0.8	0.1	0.28	0.75	0.29	-0.23	0.98	0.19	0.55	0.84
Net Tangible Assets	0.78	0.13	0.53	0.72	0.31		0.56	-0.11	-0.56	0.53	0.46	0.46	0.31	0.46	0.72	-0.66	0.8	0.89	0.67	0.8	0.61	0.73	0.39	0.45	0.51	0.7
Property Plant And Equipment Net	0.45	0.52	0.45	0.15	0.65	0.56		0.44	-0.82	0.68	0.05	0.97	0.49	0.95	0.24	-0.56	0.81	0.48	0.85	0.85	0.7	0.27	0.78	0.81	0.35	0.81
Net Debt	-0.5	-0.19	-0.45	-0.59	0.63	-0.11	0.44		-0.58	-0.03	-0.85	0.41	0.79	0.38	-0.63	-0.2	0.38	-0.17	0.16	0.3	-0.2	-0.62	0.63	0.27	0.0	0.44
Retained Earnings	-0.2	-0.3	-0.33	0.07	-0.94	-0.56	-0.82	-0.58		-0.6	0.24	-0.84	-0.85	-0.7	0.01	0.68	-0.94	-0.37	-0.54	-0.92	-0.48	-0.02	-0.97	-0.43	-0.61	-0.94
Accounts Payable	0.59	0.76	0.8	0.24	0.5	0.53	0.68	-0.03	-0.6		0.39	0.76	0.17	0.76	0.44	-0.55	0.65	0.46	0.73	0.66	0.86	0.46	0.61	0.6	0.34	0.66
Cash	0.84	0.49	0.73	0.78	-0.43	0.46	0.05	-0.85	0.24	0.39		0.04	-0.64	0.12	0.88	-0.18	0.0	0.54	0.38	0.1	0.64	0.88	-0.35	0.23	0.11	-0.07
Non Current Assets Total	0.38	0.64	0.52	0.02	0.72	0.46	0.97	0.41	-0.84	0.76	0.04		0.48	0.94	0.15	-0.54	0.78	0.34	0.77	0.82	0.72	0.18	0.84	0.72	0.39	0.79
Non Currrent Assets Other	-0.21	-0.17	-0.13	-0.31	0.88	0.31	0.49	0.79	-0.85	0.17	-0.64	0.48		0.33	-0.34	-0.48	0.74	0.15	0.17	0.65	-0.01	-0.33	0.84	0.11	0.43	0.77
Other Assets	0.47	0.62	0.49	0.14	0.51	0.46	0.95	0.38	-0.7	0.76	0.12	0.94	0.33		0.26	-0.51	0.69	0.44	0.9	0.72	0.75	0.29	0.68	0.9	0.23	0.7
Cash And Short Term Investments	0.97	0.3	0.72	0.95	-0.25	0.72	0.24	-0.63	0.01	0.44	0.88	0.15	-0.34	0.26		-0.3	0.28	0.84	0.54	0.34	0.68	1.0	-0.16	0.41	0.23	0.25
Net Receivables	-0.41	-0.44	-0.51	-0.13	-0.52	-0.66	-0.56	-0.2	0.68	-0.55	-0.18	-0.54	-0.48	-0.51	-0.3		-0.76	-0.61	-0.59	-0.74	-0.65	-0.32	-0.56	-0.38	-0.46	-0.63
Capital Surpluse	0.45	0.26	0.44	0.23	0.8	0.8	0.81	0.38	-0.94	0.65	0.0	0.78	0.74	0.69	0.28	-0.76		0.62	0.66	0.97	0.58	0.3	0.86	0.5	0.63	0.96
Inventory	0.87	0.16	0.58	0.81	0.1	0.89	0.48	-0.17	-0.37	0.46	0.54	0.34	0.15	0.44	0.84	-0.61	0.62		0.71	0.61	0.66	0.85	0.19	0.57	0.32	0.6
Other Current Assets	0.7	0.53	0.55	0.44	0.28	0.67	0.85	0.16	-0.54	0.73	0.38	0.77	0.17	0.9	0.54	-0.59	0.66	0.71		0.67	0.8	0.57	0.46	0.94	0.11	0.64
Other Stockholder Equity	0.51	0.34	0.5	0.28	0.75	0.8	0.85	0.3	-0.92	0.66	0.1	0.82	0.65	0.72	0.34	-0.74	0.97	0.61	0.67		0.65	0.36	0.81	0.5	0.67	0.92
Total Liab	0.81	0.84	0.93	0.46	0.29	0.61	0.7	-0.2	-0.48	0.86	0.64	0.72	-0.01	0.75	0.68	-0.65	0.58	0.66	0.8	0.65		0.7	0.42	0.67	0.35	0.57
Total Current Assets	0.98	0.32	0.74	0.94	-0.23	0.73	0.27	-0.62	-0.02	0.46	0.88	0.18	-0.33	0.29	1.0	-0.32	0.3	0.85	0.57	0.36	0.7		-0.13	0.43	0.23	0.27
Property Plant Equipment	0.05	0.34	0.28	-0.24	0.98	0.39	0.78	0.63	-0.97	0.61	-0.35	0.84	0.84	0.68	-0.16	-0.56	0.86	0.19	0.46	0.81	0.42	-0.13		0.38	0.51	0.88
Short Long Term Debt Total	0.56	0.47	0.39	0.33	0.19	0.45	0.81	0.27	-0.43	0.6	0.23	0.72	0.11	0.9	0.41	-0.38	0.5	0.57	0.94	0.5	0.67	0.43	0.38		-0.01	0.52
Current Deferred Revenue	0.3	0.2	0.41	0.19	0.55	0.51	0.35	0.0	-0.61	0.34	0.11	0.39	0.43	0.23	0.23	-0.46	0.63	0.32	0.11	0.67	0.35	0.23	0.51	-0.01		0.58
Long Term Debt	0.42	0.25	0.45	0.21	0.84	0.7	0.81	0.44	-0.94	0.66	-0.07	0.79	0.77	0.7	0.25	-0.63	0.96	0.6	0.64	0.92	0.57	0.27	0.88	0.52	0.58

Click cells to compare fundamentals

Exicure Account Relationship Matchups

Exicure fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	115.3M	100.4M	64.9M	23.3M	11.6M	11.0M
Other Current Liab	2.1M	3.3M	11.8M	739K	253K	240.4K
Total Current Liabilities	31.1M	13.7M	34.1M	1.6M	2.5M	2.4M
Total Stockholder Equity	80.7M	61.5M	11.2M	14.9M	3.0M	2.9M
Other Liab	836K	3.4M	656K	12.2M	14.0M	14.7M
Net Tangible Assets	80.7M	61.5M	11.2M	14.9M	17.2M	20.0M
Property Plant And Equipment Net	2.5M	12.7M	11.9M	9.8M	6.6M	5.7M
Net Debt	(43.1M)	(8.5M)	(19.9M)	(1.3M)	5.8M	6.1M
Retained Earnings	(81.3M)	(106.0M)	(170.1M)	(172.6M)	(189.6M)	(180.1M)
Accounts Payable	1.8M	1.9M	3.4M	361K	1.6M	1.4M
Cash	48.5M	33.3M	34.6M	8.6M	816K	775.2K
Non Current Assets Total	2.5M	14.1M	21.2M	13.3M	9.6M	7.8M
Cash And Short Term Investments	110.8M	82.1M	39.1M	8.6M	816K	775.2K
Net Receivables	3K	35K	11K	0.0	111K	14.3K
Capital Surpluse	53.6M	75.9M	162.1M	167.4M	192.5M	202.1M
Other Current Assets	2.0M	7.3M	4.5M	1.5M	1.2M	2.4M
Other Stockholder Equity	162.1M	167.4M	181.3M	187.6M	192.6M	120.3M
Total Liab	34.5M	38.9M	53.6M	8.4M	8.5M	8.1M
Total Current Assets	112.8M	86.3M	43.7M	10.1M	2.0M	1.9M
Property Plant Equipment	2.5M	4.1M	11.9M	9.8M	11.3M	11.8M
Short Long Term Debt Total	5.3M	24.8M	14.7M	7.3M	6.7M	10.2M
Common Stock Shares Outstanding	1.9M	2.9M	3.0M	4.6M	8.0M	8.4M
Liabilities And Stockholders Equity	115.3M	100.4M	64.9M	23.3M	11.6M	11.0M
Non Current Liabilities Total	3.4M	25.2M	19.6M	6.8M	6.0M	10.8M
Property Plant And Equipment Gross	2.5M	12.7M	14.5M	9.8M	6.8M	6.8M
Accumulated Other Comprehensive Income	(1.2M)	(27K)	83K	(2K)	(2.3K)	(2.4K)
Non Current Liabilities Other	39K	59K	8.6M	656K	754.4K	716.7K
Net Invested Capital	85.7M	78.1M	18.1M	14.9M	3.0M	2.9M
Net Working Capital	81.7M	72.6M	9.6M	8.4M	(486K)	(461.7K)

Pair Trading with Exicure

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Exicure position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exicure will appreciate offsetting losses from the drop in the long position's value.

Moving against Exicure Stock

0.63	MREO	Mereo BioPharma Group	Pair Corr
0.57	PDSB	PDS Biotechnology Corp	Pair Corr
0.53	IVVD	Invivyd	Pair Corr
0.51	PEPG	PepGen	Pair Corr
0.45	NKTX	Nkarta Inc	Pair Corr

The ability to find closely correlated positions to Exicure could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Exicure when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Exicure - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Exicure to buy it.

The correlation of Exicure is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Exicure moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Exicure moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Exicure can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Exicure Stock Analysis

When running Exicure's price analysis, check to measure Exicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Exicure is operating at the current time. Most of Exicure's value examination focuses on studying past and present price action to predict the probability of Exicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Exicure's price. Additionally, you may evaluate how the addition of Exicure to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC